insitro and Bristol Myers Squibb have announced the next phase of their collaboration to discover novel therapies for amyotrophic lateral sclerosis (ALS), leveraging insitro’s...
AcuraStem, a patient-based biotechnology company pioneering the development of treatments for amyotrophic lateral sclerosis (ALS) and additional neurodegenerative diseases, announced the appointment of Marcel...
Mitsubishi Tanabe Pharma America, Inc., announced the presentation of five abstracts in amyotrophic lateral sclerosis (ALS) at the XXVI World Congress of Neurology (WCN),...
Verge Genomics, a clinical-stage, tech-enabled biotechnology company pioneering the use of artificial intelligence (AI) and human data to transform drug discovery and development, announced...
Ionis Pharmaceuticals, Inc. announced that its partner Biogen has received U.S. Food and Drug Administration (FDA) approval of QALSODY 100 mg/15mL injection for the...
